Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Aptorum group limited crawled date : 2021 - 04 - 22 save search
Aptorum Enters Agreement With Yale to Develop, Investigate Novel Immunomodulators
Published: 2021-04-22 (Crawled : 18:00) - biospace.com/
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: -0.93%
H: 0.27%
C: 0.17%
APM | $7.85 -6.07% 9.9K
|
Health Technology
|
| O: 4.45%
H: 5.43%
C: -1.94%
ev
Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
Published: 2021-04-22 (Crawled : 12:00) - biospace.com/
APM | $7.85 -6.07% 9.9K
|
Health Technology
|
| O: 4.45%
H: 5.43%
C: -1.94%
disease potential license
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.